Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 417

1.

Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.

Grieger JC, Samulski RJ.

Adv Biochem Eng Biotechnol. 2005;99:119-45. Review.

PMID:
16568890
2.

Overview of adeno-associated viral vectors.

Daly TM.

Methods Mol Biol. 2004;246:157-65. Review.

PMID:
14970590
3.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

High KA.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2. Review.

4.

Gene therapy: recombinant adeno-associated virus vectors.

Smith-Arica JR, Bartlett JS.

Curr Cardiol Rep. 2001 Jan;3(1):43-9. Review.

PMID:
11139798
5.

Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.

Couto LB.

Semin Thromb Hemost. 2004 Apr;30(2):161-71. Review.

PMID:
15118928
6.

Adeno-associated viral vectors for gene transfer and gene therapy.

B├╝eler H.

Biol Chem. 1999 Jun;380(6):613-22. Review.

PMID:
10430026
7.

Adeno-associated virus serotypes: vector toolkit for human gene therapy.

Wu Z, Asokan A, Samulski RJ.

Mol Ther. 2006 Sep;14(3):316-27. Review.

PMID:
16824801
9.

The state of the art of adeno-associated virus-based vectors in gene therapy.

Coura Rdos S, Nardi NB.

Virol J. 2007 Oct 16;4:99. Review. Erratum in: Virol J. 2010;7:12.

10.

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

Conway JE, Rhys CM, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ.

Gene Ther. 1999 Jun;6(6):986-93.

11.

AAV-mediated gene transfer for hemophilia.

High KA.

Ann N Y Acad Sci. 2001 Dec;953:64-74. Review.

PMID:
11795424
12.

Current development of adeno-associated viral vectors.

Romano G.

Drug News Perspect. 2005 Jun;18(5):311-6. Review.

PMID:
16193103
13.
14.

Production and purification of recombinant adeno-associated vectors.

Wang L, Blouin V, Brument N, Bello-Roufai M, Francois A.

Methods Mol Biol. 2011;807:361-404. doi: 10.1007/978-1-61779-370-7_16.

PMID:
22034039
15.

A helper virus-free packaging system for recombinant adeno-associated virus vectors.

Collaco RF, Cao X, Trempe JP.

Gene. 1999 Oct 1;238(2):397-405.

PMID:
10570967
16.

Adeno-associated virus vectorology, manufacturing, and clinical applications.

Grieger JC, Samulski RJ.

Methods Enzymol. 2012;507:229-54. doi: 10.1016/B978-0-12-386509-0.00012-0. Review.

PMID:
22365777
17.

rAAV vector-mediated gene therapy for experimental ischemic stroke.

Li ZJ, Wang RZ.

Neurol India. 2008 Apr-Jun;56(2):116-21. Review.

18.

Clinical gene therapy using recombinant adeno-associated virus vectors.

Mueller C, Flotte TR.

Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Review.

PMID:
18418415
19.

The use of recombinant adeno-associated virus for skeletal gene therapy.

Dai J, Rabie AB.

Orthod Craniofac Res. 2007 Feb;10(1):1-14. Review.

PMID:
17284242
20.

Gene transfer into hematopoietic progenitor and stem cells: progress and problems.

Dunbar CE, Emmons RV.

Stem Cells. 1994 Nov;12(6):563-76. Review.

PMID:
7881358
Items per page

Supplemental Content

Support Center